Form D · Investing

Novus Biotechnology Fund 1, L.P.

Portage, MI · CIK 0001622840

Offering snapshot reported Jul 2, 2015 · SEC filing

Reported sold
$2M
Offering amount: $20M
Investors reported
17
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Jun 25, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1M$2MNov 13, 2014: $2,000,000.00Nov 13, 2014Jul 2, 2015: $2,000,000.00Jul 2, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 2, 2015Amendment$2,000,000$0vs Nov 13, 201417SEC filing
Nov 13, 2014Initial$2,000,000No comparison17SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0
Form D file number
021-228209

Source: Form D, filed Jul 2, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kenneth Easton Executive
John Keller Executive
Kevin Mc Leod Executive
Matthew John Milanowski Executive
Frank Saltiel Executive
Gregory Schultz Executive

Issuer details

Industry: Investing (See others in industry)

Address:
1151 W. Milham Ave Suite 758
Portage, MI, 49081